Arcadia Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
20,470
+5,365
| +36% | +$468K | 0.29% | 57 |
|
|
2025
Q1 | $1.03M | Sell |
15,105
-3,585
| -19% | -$245K | 0.19% | 69 |
|
|
2024
Q4 | $1.45M | Sell |
18,690
-1,110
| -6% | -$86.3K | 0.23% | 60 |
|
|
2024
Q3 | $1.33M | Buy |
19,800
+18,165
| +1,111% | +$1.22M | 0.22% | 67 |
|
|
2024
Q2 | $185K | Buy |
1,635
+1,615
| +8,075% | +$183K | 0.03% | 122 |
|
|
2024
Q1 | $2.77K | Sell |
20
-394
| -95% | -$54.6K | ﹤0.01% | 299 |
|
|
2023
Q4 | $51.4K | Hold |
414
| – | – | 0.01% | 210 |
|
|
2023
Q3 | $38.6K | Hold |
414
| – | – | 0.01% | 229 |
|
|
2023
Q2 | $53.2K | Buy |
414
+410
| +10,250% | +$52.7K | 0.01% | 215 |
|
|
2023
Q1 | $465 | Hold |
4
| – | – | ﹤0.01% | 347 |
|
|
2022
Q4 | $453 | Hold |
4
| – | – | ﹤0.01% | 343 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 280 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 290 |
|
|
2022
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 280 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 284 |
|
|
2021
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 267 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 297 |
|
|
2021
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 282 |
|
|
2016
Q3 | – | Sell |
-364
| Closed | -$7K | – | 361 |
|
|
2016
Q2 | $7K | Buy |
+364
| New | +$7K | ﹤0.01% | 413 |
|